Daré Bioscience (NASDAQ:DARE) Share Price Crosses Above Fifty Day Moving Average – Time to Sell?

Shares of Daré Bioscience, Inc. (NASDAQ:DARE) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $3.36 and traded as high as $3.38. Daré Bioscience shares last traded at $3.33, with a volume of 49,228 shares traded.

Analyst Ratings Changes

Separately, HC Wainwright reissued a “buy” rating and set a $12.00 target price on shares of Daré Bioscience in a research note on Tuesday, December 17th.

Daré Bioscience Stock Performance

The company has a market cap of $28.97 million, a PE ratio of -5.64 and a beta of 1.28. The firm’s 50 day moving average is $3.36 and its 200-day moving average is $3.43.

Institutional Trading of Daré Bioscience

An institutional investor recently raised its position in Daré Bioscience stock. Renaissance Technologies LLC raised its position in Daré Bioscience, Inc. (NASDAQ:DARE) by 2.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 778,700 shares of the biotechnology company’s stock after purchasing an additional 15,800 shares during the quarter. Renaissance Technologies LLC owned about 9.25% of Daré Bioscience worth $262,000 as of its most recent SEC filing. Institutional investors own 6.70% of the company’s stock.

About Daré Bioscience

Daré Bioscience, Inc, a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older.